Patient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials
Authors:
- Jesús San-MiguelJSJesús San-Miguel
- Saad UsmaniSUSaad Usmani
- Sonja ZweegmanSZSonja Zweegman
- Philippe MoreauPMPhilippe Moreau
- Mario BoccadoroMBMario Boccadoro
- Meletios DimopoulosMDMeletios Dimopoulos
- Hermann EinseleHEHermann Einsele
- Paula Rodríguez-OteroPRPaula Rodríguez-Otero
- Thierry FaconTFThierry Facon
- J. Blake BartlettJBJ. Blake Bartlett
- Thomas PriorTPThomas Prior
- Katharine GriesKGKatharine Gries
- 17 September 2025
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 25, S368